Haematolymphoid Tumours is Volume 11 in the 5th edition of the WHO series on the classification of human tumours. This series (also known as the WHO Blue Books) is regarded as the gold standard for the diagnosis of tumours and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise reference books provide indispensable international standards for anyone involved in the care of patients with cancer or in cancer research, underpinning individual patient treatment as well as research into all aspects of cancer causation, prevention, therapy, and education.

What's new in this edition?
The 5th edition, guided by the WHO Classification of Tumours Editorial Board, establishes a single coherent cancer classification presented across a collection of individual volumes organized on the basis of anatomical site (digestive system, breast, soft tissue and bone, etc.) and structured in a systematic manner, with each tumour type listed within a taxonomic classification: site, category, family (class), type, and subtype. In each volume, the entities are now listed from benign to malignant and are described under an updated set of headings, including histopathology, diagnostic molecular pathology, staging, and easy-to-read essential and desirable diagnostic criteria.

Who should read this book?

(Haemato)pathologists
Haematologists
(Haemato)oncologists
Radiation oncologists
Radiologists
Nuclear medicine specialists
Molecular pathologists
Geneticists
Immunologists
Cancer researchers
Epidemiologists
General practitioners
Oncology nurses
Cancer registrars
This volume

Prepared by 422 authors and editors
Contributors from around the world
More than 1600 high-quality images
More than 5000 references
Part A

1. General introduction to haematolymphoid tumours
2. Myeloid proliferations and neoplasms
3. Histiocytic/dendritic cell neoplasms

Part B

4. B-cell lymphoid proliferations and lymphomas
5. T-cell and NK-cell lymphoid proliferations and lymphomas
6. Stroma-derived neoplasms of lymphoid tissues
7. Genetic tumour syndromes associated with haematolymphoid tumours